7-[(1R,2R,3R)-2-[4,4-difluoro-3-hydroxy(6,6,7,7,8,8,8-2H7)octyl]-3-hydroxy-5-oxocyclopentyl]heptanoic acid; N-cyclohexylcyclohexanamine

• ChemBase编号: 170711
• 分子式: C32H57F2NO5
• 平均质量: 573.7954864
• 单一同位素质量: 573.42048037
• SMILES: C1(CCCCC1)NC1CCCCC1.[C@@H]1(CCC(C(CCCC)(F)F)O)[C@H](C(=O)C[C@H]1O)CCCCCCC(=O)O
• Canonical SMILES: C1CCC(CC1)NC1CCCCC1.CCCCC(C(CC[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O)O)(F)F
• InChI: InChI=1S/C20H34F2O5.C12H23N/c1-2-3-12-20(21,22)18(25)11-10-15-14(16(23)13-17(15)24)8-6-4-5-7-9-19(26)27;1-3-7-11(8-4-1)13-12-9-5-2-6-10-12/h14-15,17-18,24-25H,2-13H2,1H3,(H,26,27);11-13H,1-10H2/t14-,15-,17-,18?;/m1./s1
• InChIKey: QJDFENRVJAVPMD-SXQXKTMOSA-N

名称和登记号

名称

• IUPAC标准名: 7-[(1R,2R,3R)-2-[4,4-difluoro-3-hydroxy(6,6,7,7,8,8,8-^2H₇)octyl]-3-hydroxy-5-oxocyclopentyl]heptanoic acid; N-cyclohexylcyclohexanamine
• IUPAC传统名: 7-[(1R,2R,3R)-2-[4,4-difluoro-3-hydroxy(6,6,7,7,8,8,8-^2H₇)octyl]-3-hydroxy-5-oxocyclopentyl]heptanoic acid; dicha
• 别名: (11α)-16,16-Difluoro-11,15-dihydroxy-9-oxoprostan-1-oic Acid-d7; Dicyclohexylammonium Salt; 13,14-Dihydro-16,16-difluoroprostaglandin E1-d7 Dicyclohexylammonium Salt; 15-Hydroxy Lubiprostone Dicyclohexylammonium Salt-d7

登记号

• PubChem SID: 164226621
• PubChem CID: 71749096

理论计算性质

• Acid pKa: 4.30448
• 质子受体: 5
• 质子供体: 3
• LogD (pH = 5.5): 2.6002276
• LogD (pH = 7.4): 0.8608489
• Log P: 3.8205786
• 摩尔折射率: 97.5333 cm^3
• 极化性: 38.21315 Å^3
• 极化表面积: 94.83 Å^2
• 可自由旋转的化学键: 16
• 里宾斯基五规则: false

分子性质

理化性质

• 溶解度: Chloroform; Methanol
• 外观: White Foam

安全信息

• 保存条件: -20°C Freezer, Under Inert Atmosphere
• 保存注意事项: -86 freezer

详细说明

Toronto Research Chemicals - H943892

A halogenated labelled bioactive lipid; a prostaglandin analog as chloride channel opener for the treatment of gastrointestinal disorder.

参考文献

• Dalemans, W., et al.: Nature, 354, 526 (1991)
• Sakai, H., et al.: J. Biol. Chem., 270, 18781 (1991)
• Chan, L., et al.: Biology Reprod., 60, 374 (1991)